# [18F]Fluoroestradiol-PET/CT Imaging of Invasive Lobular Carcinoma

> **NCT04252859** · PHASE2 · TERMINATED · sponsor: **University of Utah** · enrollment: 44 (actual)

## Conditions studied

- Invasive Lobular Breast Carcinoma

## Interventions

- **DRUG:** [18F]Fluoroestradiol (FES) PET/CT

## Key facts

- **NCT ID:** NCT04252859
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-12-11
- **Primary completion:** 2024-12-07
- **Final completion:** 2024-12-07
- **Target enrollment:** 44 (ACTUAL)
- **Why stopped:** PI is leaving the institution.
- **Last updated:** 2025-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04252859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04252859, "[18F]Fluoroestradiol-PET/CT Imaging of Invasive Lobular Carcinoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04252859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*